Yousif Capital Management LLC Has $28.34 Million Holdings in Intuitive Surgical, Inc. $ISRG

Yousif Capital Management LLC cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.6% during the second quarter, HoldingsChannel.com reports. The firm owned 52,152 shares of the medical equipment provider’s stock after selling 865 shares during the quarter. Yousif Capital Management LLC’s holdings in Intuitive Surgical were worth $28,340,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Chilton Capital Management LLC lifted its position in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the period. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $30,000. TD Capital Management LLC raised its position in shares of Intuitive Surgical by 300.0% in the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock valued at $30,000 after acquiring an additional 45 shares during the period. Finally, 1248 Management LLC acquired a new stake in shares of Intuitive Surgical in the 1st quarter valued at approximately $30,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This trade represents a 59.69% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the transaction, the director directly owned 1,074 shares of the company’s stock, valued at $504,898.14. This represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 3.2%

Shares of ISRG opened at $429.59 on Monday. The stock has a market capitalization of $154.00 billion, a P/E ratio of 59.91, a P/E/G ratio of 4.51 and a beta of 1.61. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The company has a 50 day moving average of $458.68 and a 200-day moving average of $497.84.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, topping the consensus estimate of $1.93 by $0.26. The company had revenue of $2.44 billion during the quarter, compared to analysts’ expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s quarterly revenue was up 21.4% on a year-over-year basis. During the same period last year, the business earned $1.78 EPS. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on ISRG shares. Truist Financial increased their price target on shares of Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a research report on Wednesday, July 23rd. Evercore ISI cut their price target on shares of Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating on the stock in a research report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Wednesday, October 8th. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.